NO20001673L - Farmasøytiske blandinger for oral administrering av molekylært jod - Google Patents

Farmasøytiske blandinger for oral administrering av molekylært jod

Info

Publication number
NO20001673L
NO20001673L NO20001673A NO20001673A NO20001673L NO 20001673 L NO20001673 L NO 20001673L NO 20001673 A NO20001673 A NO 20001673A NO 20001673 A NO20001673 A NO 20001673A NO 20001673 L NO20001673 L NO 20001673L
Authority
NO
Norway
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical compositions
Prior art date
Application number
NO20001673A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001673D0 (no
Inventor
Yongun Duan
John Hickey
Rick Panicucci
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of NO20001673D0 publication Critical patent/NO20001673D0/no
Publication of NO20001673L publication Critical patent/NO20001673L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20001673A 1997-10-29 2000-03-31 Farmasøytiske blandinger for oral administrering av molekylært jod NO20001673L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (2)

Publication Number Publication Date
NO20001673D0 NO20001673D0 (no) 2000-03-31
NO20001673L true NO20001673L (no) 2000-05-24

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001673A NO20001673L (no) 1997-10-29 2000-03-31 Farmasøytiske blandinger for oral administrering av molekylært jod

Country Status (17)

Country Link
US (1) US5885592A (enExample)
EP (1) EP1024815B1 (enExample)
JP (1) JP4187410B2 (enExample)
KR (1) KR100412219B1 (enExample)
CN (1) CN1150904C (enExample)
AT (1) ATE231725T1 (enExample)
AU (1) AU750627B2 (enExample)
BR (1) BR9812588A (enExample)
CA (1) CA2301503C (enExample)
DE (1) DE69811105T2 (enExample)
DK (1) DK1024815T3 (enExample)
ES (1) ES2191973T3 (enExample)
IL (1) IL134778A0 (enExample)
NO (1) NO20001673L (enExample)
PT (1) PT1024815E (enExample)
RU (1) RU2213564C2 (enExample)
WO (1) WO1999021567A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
JP4586018B2 (ja) * 2003-06-20 2010-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 猫における甲状腺機能亢進症を予防する方法及び限定されたヨウ素を含む組成物
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
RU2432941C2 (ru) * 2006-01-26 2011-11-10 Хилл'С Пет Ньютришн, Инк. Способы и композиции для лечения гипертиреоза у кошачьих
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CN101511205A (zh) * 2006-07-03 2009-08-19 希尔氏宠物营养品公司 用于在甲状腺机能亢进的猫科动物中预防或治疗心血管疾病的组合物和方法
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
KR20140033123A (ko) * 2011-05-16 2014-03-17 쇼칸 사비르하노비치 베갈리예프 항바이러스성, 항궤양 및 면역 자극 작용을 가지고, 르네상스라는 이름을 가지는 의학 조제물
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
WO2015153258A1 (en) 2014-03-31 2015-10-08 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
AU2017300497A1 (en) 2016-07-21 2019-03-14 I2Pure Corp. Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
IL134778A0 (en) 2001-04-30
AU750627B2 (en) 2002-07-25
ES2191973T3 (es) 2003-09-16
PT1024815E (pt) 2003-06-30
EP1024815B1 (en) 2003-01-29
AU1122799A (en) 1999-05-17
DE69811105D1 (de) 2003-03-06
CA2301503A1 (en) 1999-05-06
RU2213564C2 (ru) 2003-10-10
DK1024815T3 (da) 2003-05-19
ATE231725T1 (de) 2003-02-15
JP2003510243A (ja) 2003-03-18
KR20010030861A (ko) 2001-04-16
WO1999021567A1 (en) 1999-05-06
JP4187410B2 (ja) 2008-11-26
EP1024815A1 (en) 2000-08-09
CA2301503C (en) 2005-01-04
KR100412219B1 (ko) 2003-12-24
NO20001673D0 (no) 2000-03-31
BR9812588A (pt) 2000-07-25
CN1150904C (zh) 2004-05-26
CN1272789A (zh) 2000-11-08
DE69811105T2 (de) 2003-11-06
US5885592A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
NO20001673L (no) Farmasøytiske blandinger for oral administrering av molekylært jod
DE69831869D1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
IL208184A0 (en) Glp-1, and methods for treating diabetes
ATE394107T1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
MXPA02010322A (es) Metodos para la prevencion y tratamiento de trastornos gastrointestinales.
NO883414D0 (no) Antistoff-enzymkonjugater i kombinasjon med prolegemidler til fremfoeing av cytotoksiske midler til tumorceller.
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP1064950A4 (en) NEW REMEDIES AGAINST HEPATITIS
HK1046089A1 (zh) 褪黑激素的治疗用途
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
IL120303A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
SE8701077D0 (sv) Pharmaceutical composition
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
CA2197139A1 (en) A drug for the treatment of cancer
UA66809C2 (uk) Спосіб лікування гіперглікемії похідною тіазолідиндіону
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
UA10436A (uk) Спосіб лікуваhhя виразкової хвороби шлуhку та дваhадцятипалої кишки
TW357092B (en) Transport of solid medicament components
AU8716001A (en) Treatment of hepatitis c with thymosin and pegylated interferon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application